Parts and ICRAFTs: Finding new immunotherapy targets.

Immunity
Authors
Abstract

CRISPR screens are widely utilized to identify genes that regulate immune function or mediate sensitivity of cancer cells to immune attack. In this issue of Immunity, Zeng et al. present a computational framework for uncovering gene targets with dual function in both cancer and immune cells and nominate TNFAIP3 as a synergistic target whose ablation strongly elicits an antitumor response.

Year of Publication
2025
Journal
Immunity
Volume
58
Issue
3
Pages
529-531
Date Published
03/2025
ISSN
1097-4180
DOI
10.1016/j.immuni.2025.02.016
PubMed ID
40073844
Links